Showing 201 - 220 results of 273 for search '"Yey!"', query time: 0.11s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206

    Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma by Zhou Y, Zhao Z, Li J, Zhang B, Sang S, Wu Y, Deng S

    Published 2019-07-01
    “…Yeye Zhou,* Zixuan Zhao,* Jihui Li, Bin Zhang, Shibiao Sang, Yiwei Wu,* Shengming DengDepartment of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China*These authors contributed equally to this workPurpose: In the present study, we aimed to investigate the role of baseline, interim and end-of treatment positron emission tomography/computed tomography (PET/CT) in assessing the prognosis of follicular lymphoma (FL).Methods: A total of 84 FL patients were retrospectively analyzed in this study. …”
    Get full text
    Article
  7. 207

    Postoperative Short-term Outcomes Between Sublobar Resection and Lobectomy in Patients with Lung Adenocarcinoma by Zhang J, Bai W, Guo C, Liu L, Wang G, Huang C, Chen Y, Zhang Y, Li S

    Published 2020-10-01
    “…Jiaqi Zhang ,* Wenliang Bai ,* Chao Guo, Lei Liu, Guige Wang, Cheng Huang, Yeye Chen, Ye Zhang, Shanqing Li Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shanqing Li Tel +86 13121971623Fax +86 1069152630Email 13121971623@163.comBackground: To investigate postoperative temporary consequences of the enrolled patients with lung adenocarcinoma.Patients and Methods: We analyzed the clinical data of patients with lung adenocarcinoma admitted by the same surgical team of Peking Union Medical College Hospital (PUMCH) from July 2019 to December 2019. …”
    Get full text
    Article
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220

    In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii by Zhang H, Zhu Y, Yang N, Kong Q, Zheng Y, Lv N, Chen H, Yue C, Liu Y, Li J, Ye Y

    Published 2021-11-01
    “…Hui Zhang,1 Yunzhu Zhu,1 Ning Yang,1 Qinxiang Kong,2 Yahong Zheng,1 Na Lv,1 Haoran Chen,1 Chengcheng Yue,1 Yanyan Liu,1,3,4 Jiabin Li,1– 4 Ying Ye1 1Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic of China; 2Department of Infectious Diseases, The Chaohu Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic of China; 3Anhui Center for Surveillance of Bacterial Resistance, Hefei, Anhui, People’s Republic of China; 4Institute of Bacterial Resistance, Anhui Medical University, Hefei, Anhui, People’s Republic of ChinaCorrespondence: Ying Ye; Jiabin LiDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Jixi Road no. 218, Hefei, Anhui, People’s Republic of ChinaTel +86-551-62922713Fax +86-551-62922281Email yeying2@139.com; lijiabin@ahmu.edu.cnPurpose: To study the in vitro and in vivo antibacterial activities of polymyxin B (PB) and other five antimicrobial agents, including imipenem (IMP), meropenem (MEM), tigecycline (TGC), sulbactam (SUL), and rifampicin (RIF), alone or in combination against carbapenem-resistant Acinetobacter baumannii (CRAB).Methods: Microbroth dilution method was used to determine the minimum inhibitory concentration (MIC) of ten strains of CRAB against six antibacterial drugs, and the checkerboard method was used to determine the fractional inhibitory concentration index (FICI). …”
    Get full text
    Article